Michael John Sumner is Chief Medical Officer of INOVIO PHARMACEUTICALS, INC.. Currently has a direct ownership of 17,850 shares of INO, which is worth approximately $23,740. The most recent transaction as insider was on Jun 30, 2025, when has been sold 2,916 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.9K
34.93% 3M change
117.18% 12M change
Total Value Held $23,740

Michael John Sumner Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2025
BUY
Exercise of conversion of derivative security
-
2,916 Added 14.04%
17,850 Common Stock
May 15 2025
SELL
Payment of exercise price or tax liability
$1,326 $1.95 p/Share
680 Reduced 4.36%
14,934 Common Stock
May 15 2025
BUY
Exercise of conversion of derivative security
-
2,385 Added 13.25%
15,614 Common Stock
Feb 26 2025
BUY
Exercise of conversion of derivative security
-
5,010 Added 27.47%
13,229 Common Stock
Jun 30 2024
BUY
Exercise of conversion of derivative security
-
2,917 Added 26.19%
8,219 Common Stock
May 15 2024
BUY
Exercise of conversion of derivative security
-
2,386 Added 31.04%
5,302 Common Stock
Jun 30 2023
BUY
Exercise of conversion of derivative security
-
35,000 Added 50.0%
35,000 Common Stock
MJS

Michael John Sumner

Chief Medical Officer
Plymouth Meeting, PA

Track Institutional and Insider Activities on INO

Follow INOVIO PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INO shares.

Notify only if

Insider Trading

Get notified when an Inovio Pharmaceuticals, Inc. insider buys or sells INO shares.

Notify only if

News

Receive news related to INOVIO PHARMACEUTICALS, INC.

Track Activities on INO